PDCD1 and neoplasm: Programmed death 1 (PD1), recognized as a pivotal immune checkpoint molecule, engages with programmed death ligands L1/L2 (PD‐L1/L2) to transmit an inhibitory signal, thereby suppressing effector function and allowing cancer cells to evade tumour immunity.4